
AVAH Stock Forecast & Price Target
AVAH Analyst Ratings
Bulls say
Aveanna Healthcare Holdings Inc. demonstrated robust performance across its segments, with Home Health & Hospice revenue increasing by 27.3% year-over-year to $69.3 million, while gross margin expanded to 53.7%, surpassing target ranges. The Medical Solutions segment also showed significant growth, with revenue rising 21.3% to $52.5 million and gross margin improving markedly to 50.0%, aided by effective cash collections. Further, the Private Duty Services segment experienced a notable 28.1% year-over-year revenue increase driven by strong volume and rate growth, supported by positive contributions from the Thrive acquisition, which is set to enhance operational efficiencies.
Bears say
Aveanna Healthcare Holdings Inc. exhibits a concerning decline in financial performance characterized by a decrease in the Private Duty Nursing (PDN) spread rate, which fell to $12.12 from a previous range of $12.60, indicating ongoing wage pressures amid efforts to support higher service volumes. The organization faces numerous downside risks, including reimbursement pressures, difficulties in sourcing and integrating acquisitions, and substantial competition, all of which could affect future earnings and growth prospects. Additionally, adverse labor market conditions are projected to negatively influence adjusted EBITDA estimates by 10% for both FY26 and FY27, further compounding Aveanna’s financial challenges.
This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.
AVAH Analyst Forecast & Price Prediction
Start investing in AVAH
Order type
Buy in
Order amount
Est. shares
0 shares